Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (111-120 of 503) with videos related to

Pageof 51
Sort By:
British Journal of Haematology|August 16, 2005
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell deathGeorgios V Georgakis, Yang Li, Robin Humphreys, et al.
Leukemia & Lymphoma|July 15, 2006
Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center SeriesApostolia-Maria Tsimberidou, Maribel Tirado-Gomez, Michael Andreeff, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2016
High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeXin Han, L Jeffrey Medeiros, Yu Helen Zhang, et al.
Blood|July 7, 2021
Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AMLBing Z Carter, Wenjing Tao, Po Yee Mak, et al.
Cancer Research|April 5, 2005
A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemiaRooha Contractor, Ismael J Samudio, Zeev Estrov, et al.
Leukemia & Lymphoma|June 13, 2024
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinasesGuopan Yu, Weiguo Zhang, Mahesh Basyal, et al.
Blood|June 6, 2015
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemiaRongqing Pan, Vivian R Ruvolo, Jun Wei, et al.
Plos One|April 9, 2009
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progressionErika L Spaeth, Jennifer L Dembinski, A Kate Sasser, et al.
Cancer Science|October 10, 2015
Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapyYuki Nishida, Aya Maeda, Dhruv Chachad, et al.
Pageof 51

Showing results (111-120 of 503) with videos related to

Sort By:
Pageof 51
British Journal of Haematology|August 16, 2005
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell deathGeorgios V Georgakis, Yang Li, Robin Humphreys, et al.
Leukemia & Lymphoma|July 15, 2006
Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center SeriesApostolia-Maria Tsimberidou, Maribel Tirado-Gomez, Michael Andreeff, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2016
High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeXin Han, L Jeffrey Medeiros, Yu Helen Zhang, et al.
Blood|July 7, 2021
Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AMLBing Z Carter, Wenjing Tao, Po Yee Mak, et al.
Cancer Research|April 5, 2005
A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemiaRooha Contractor, Ismael J Samudio, Zeev Estrov, et al.
Leukemia & Lymphoma|June 13, 2024
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinasesGuopan Yu, Weiguo Zhang, Mahesh Basyal, et al.
Blood|June 6, 2015
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemiaRongqing Pan, Vivian R Ruvolo, Jun Wei, et al.
Plos One|April 9, 2009
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progressionErika L Spaeth, Jennifer L Dembinski, A Kate Sasser, et al.
Cancer Science|October 10, 2015
Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapyYuki Nishida, Aya Maeda, Dhruv Chachad, et al.
Pageof 51